Indication

Lymphomatoid

1 clinical trial

2 products

Clinical trial
Treatment and Natural History Study of Lymphomatoid Granulomatosis
Status: Active (not recruiting), Estimated PCD: 2030-02-01
Product
Interferon
Product
Rituxan